Unternehmensprofil der M1 Kliniken AG
Unternehmensprofil der M1 Kliniken AG

Unique business model

Company profile

M1 Kliniken AG, based in Berlin, is one of the fastest growing and leading private providers of health services in the beauty sector. With its products and services, the group of companies with more than 200 employees offers a customer-oriented spectrum of aesthetic and surgical treatments throughout Germany. Our experienced and highly specialised team uses high-quality products and state-of-the-art medical technology to perform more than 200,000 minimally invasive and surgical procedures every year to the highest quality standards.

Business model

With the guiding principle "highest quality at the best price", M1 started in 2012 and has established itself as the market leader for beauty medicine in Germany. M1 aims to achieve this leading position in the international beauty segment as well by constantly expanding abroad.

To realize this vision, M1 has developed a unique business model, which is based on specialisation and thus providing the highest quality in medicine. Experts agree on this and for us, top medicine through specialisation is the corporate DNA. M1 Kliniken is the first company to focus on selected treatments within aesthetic and plastic medicine. The results are economies of scale and affordable prices.

More than 90 highly specialized doctors perform more treatments in their field of specialty than regular doctors. This routine increases safety for our clients. Our own training and further education at the M1 Akademie also contributes to this. At the same time, centralised purchasing enables us to use the most modern technical infrastructure and the highest quality products and medicines at attractive prices. With this specialisation, M1 makes top medicine accessible to the general public.

> 200 employees

240,000 treatments annually

> 35 specialist centres worldwide

100 specialist centres by 2023

Latest news

| Corporate News

M1 Kliniken AG acquires about 48 % of the share capital of HAEMATO AG from MPH Health Care AG. Transfer of the HAEMATO shares within the framework of a capital increase through contribution in kind Focus of both companies on their respective core …

| Ad-hoc news

M1 Kliniken AG acquires ca. 48% of the shares of HAEMATO AG - transfer of the shares in a capital increase against contribution in kind of M1 Kliniken AG

| Corporate News

M1 Kliniken AG today published its consolidated financial statements for 2019. The M1 Group has increased its consolidated revenue by 18% to EUR 77.2 million (previous year: EUR 65.2 million) in the financial year 2019. The consolidated net profit for the year increased by 47% to 9.7 million euros.

| Corporate News

M1 Kliniken AG (ISIN: DE000A0STSQ8) publishes preliminary figures for the financial year 2019. In the past financial year, the M1 Group further strengthened its market leadership in Germany in the field of beauty medicine and accelerated its international expansion.